CIRDAN IMAGING LIMITED

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  -8.5%

  £8,285,372 → £7,583,962

• Cash

  +8.5%

  £1,207,759 → £1,310,880

• Net assets

  +84.8%

  £5,652,348 → £10,442,959

• Employees

  +13.5%

  111 → 126

• Operating profit

  -1,106%

  -£289,968 → -£3,497,066

• Profit before tax

  -1,972.8%

  -£146,398 → -£3,034,595

• Wages

  +35.1%

  £3,733,641 → £5,042,947

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

1. CIRDAN IMAGING LIMITED 2010-06-01 → present
2. BEECHMOUNT ENTERPRISES LIMITED 2010-05-25 → 2010-06-01

Accounting basis

FRS 102

Reporting scope

Consolidated group

Auditor

ASM (M) Ltd

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“Based on these factors, the Directors are confident that the Company has sufficient resources to continue operating for the foreseeable future and have therefore prepared the financial statements on a going concern basis.”

Group structure

1. CIRDAN IMAGING LIMITED · parent
   1. Girdan Ultra Ltd 100% · Northern Ireland · develop, supply and support healthcare information systems for the clinical laboratory market
   2. Asylia Ltd. 100% · Northern Ireland · information technology consultancy services
   3. Girdan Ultra PTY Ltd 100% · Australia · develop, supply and support healthcare information systems for the clinical laboratory market
   4. Grdan Path XL Limited 100% · Northern Ireland · develop, supply and support healthcare information systems for the clinical laboratory market

Significant events

• “In November 2025 the company closed a fundraising event which resulted in more than £6.5 million in additional funding from existing shareholders and venture debt providers.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

11

last 12 months

Capital events

5

last 24 months

Officers appointed

0

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.